Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stage I Prostate Adenocarcinoma AJCC v7 1

Interventions

Cisplatin 23Magnetic Resonance Spectroscopy 18Gemcitabine 15Carboplatin 15pembrolizumab 14Specimen Handling 13Paclitaxel 13Bevacizumab 11Radiotherapy 10Nivolumab 10atezolizumab 9Doxorubicin 9Radiation 8Platinum 8Pemetrexed 8Docetaxel 81,2-diaminocyclohexaneplatinum II citrate 8Drug Therapy 7Dexamethasone 7Temozolomide 6Rituximab 6Radiotherapy, Intensity-Modulated 6Prednisone 6Ipilimumab 6Cytarabine 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6venetoclax 5Surgical Procedures, Operative 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Salicylic Acid × 90 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡